1.63% -0.16

Exagen Inc (XGN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Exagen Inc-Aktie (XGN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	10.99% 17.20	15.50	13.65	12.51	15.06
Cost Of Revenue	6.78% 6.807	6.375	5.178	5.526	6.008
Gross Profit	13.94% 10.39	9.123	8.477	6.981	9.056
Operating Expenses	4.30% 13.03	12.49	11.86	11.64	11.64
Benefits Costs and Expenses	4.30% 13.03	12.49	-5.491	17.17	17.65
Costs And Expenses	4.30% 13.03	12.49	-5.491	17.17	17.65
Operating Income/Loss	21.84% -2.63	-3.365	-3.383	-4.663	-2.587
Income/Loss From Continuing Operations Before Tax	211.33% 4.177	-3.752	19.15	-4.663	-2.966
Income Tax Expense/Benefit	0.037	-	-	-	-
Income/Loss From Continuing Operations After Tax	18.31% -4.439	-3.752	-3.761	-5.028	-2.966
Net Income/Loss	18.31% -4.439	-3.752	-3.761	-5.028	-2.966
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	13.62% 21.09	18.56	0.0755	18.25	18.18
Diluted Average Shares	13.62% 21.09	18.56	0.0755	18.25	18.18
Basic Earnings Per Share	5.00% -0.21	-0.20	-0.20	-0.28	-0.16
Diluted Earnings Per Share	5.00% -0.21	-0.20	-0.20	-0.28	-0.16
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

WAT

$306.32

2.21%

DGX

$183.49

1.88%

NTRA

$168.02

0.88%

$278.67

1.25%

MTD

$1,305.71

1.39%

IQV

$187.68

1.96%